2024 Current Concepts in Head and Neck Oncology
Saturday, November 9, 2024, 7:00 AM – Sunday, November 10, 2024, 4:00 PM
Zuckerman Research Center, 417 East 68th Street, New York, NY
This two-day course, with a 30-year track record of success, will review the latest advances in head and neck oncology. Esteemed faculty from three major cancer institutions — Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and the University of Toronto — will review the current epidemiology of head and neck and thyroid tumors, discuss how to apply multidisciplinary decision-making in the management of early-stage cancers, and explore strategies for managing advanced and complex head and neck tumors.
The course will feature a combination of individual presentations and interactive panel discussions. Attendees are encouraged to engage with all speakers, enhancing their knowledge and expanding their professional network within the head and neck oncology community. The entire faculty will be available throughout the course for any discussions you may wish to have.
The target audience for this course includes otolaryngologists, head and neck surgeons, general surgeons, radiation oncologists, medical oncologists, oral-maxillofacial surgeons, speech-language pathologists, advanced practice providers, nurses, trainees, students, and other healthcare professionals interested in the management of head and neck tumors. As this course is ideally suited for an in-person format, a virtual option will not be available.
Additional and Registration Information
3rd Annual Charleston Head & Neck Oncology Symposium
Friday, Nov. 8th – Saturday, Nov. 9th at the Sweetgrass Inn at Wild Dunes Resort
2024 Keynote Speakers
- Maie A. St. John, MD, PhD, FACS
- Theresa M. Hofstede, DDS, FACP
Additional Information & Register Now!
Harvard Medical School
Surgery of the Thyroid and Parathyroid Glands
November 15-16, 2024 | In Person: Boston, MA
Register Today
The field of thyroid and parathyroid surgery has recently undergone significant changes; thyroid cancer incidence has increased dramatically over the last several decades, technologic advances have been achieved in molecular analysis and development of targeted therapy, and thermal ablation of thyroid nodules has emerged as a promising treatment strategy. The American Thyroid Association is soon to publish a new set of medical and surgical thyroid nodule and thyroid cancer guidelines. There is a tremendous new data set that is important to convey to medical endocrinologists and thyroid and parathyroid surgeons.
This course is a 2-day course about surgery of the thyroid and parathyroid glands, which has been offered since 1996. Preoperative evaluation, management and surveillance of low-risk thyroid cancer will be reviewed. Contemporary management of advanced thyroid cancer will be covered, with topics ranging from neoadjuvant targeted therapy to surgical management of the invaded recurrent laryngeal nerve. Updates in the management of oncocytic carcinoma will be discussed. A debate will be held on thyroid ablation technology. The new Adult Complex Thyroid Surgery Focused Practice Designation will be reviewed. A range of topics in parathyroid disease will be covered, from preoperative localization to intraoperative use of autofluorescence to advances in long-acting PTH treatment for hypoparathyroidism. Panel discussions and a tumor board will highlight management options and challenges for thyroid and parathyroid conditions.
This course is targeted to Specialty Physicians.
Faculty:
Surgery of the Thyroid and Parathyroid Glands features Harvard Medical School faculty and prominent experts and leaders in their field.
Course Directors:
Gregory Randolph, MD, FACS, FACE
Marika Russell, MD, FACS
Carrie Cunningham, MD MPH
Objectives and Accreditation
Learning Objectives
Upon completion of this activity, participants will be able to:
- Describe contemporary management for low-risk thyroid cancer, including preoperative evaluation, surgical treatment, and postoperative surveillance.
- Acquire familiarity with new ATA guidelines on thyroid nodules and thyroid cancer.
- Explore recent advances the treatment of advanced thyroid cancer, including molecular analysis, neoadjuvant therapy, surgical management, and updates in pathologic classification.
- Discuss the advantages and limitations of various thermal ablation options for treatment of thyroid nodules and thyroid cancer.
- Develop and understanding of the new Adult Complex Thyroid Surgery Focused Practice Designation.
- Discuss preoperative evaluation of hyperparathyroidism, including localization studies and indications for surgery based on current guidelines.
- Evaluate the use of intraoperative parathyroid autofluorescence as an adjunctive surgical tool.
Accreditation
In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The Harvard Medical School designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Visit our website for all credits available and additional details.
